Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.20.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Aug. 31, 2018 $ 78 $ 104,918 $ (23,358) $ 81,638
Balance (in shares) at Aug. 31, 2018 78,273      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss     (8,579) (8,579)
Balance at Nov. 30, 2018 $ 79 107,256 (31,937) 75,398
Balance (in shares) at Nov. 30, 2018 78,559      
Balance at Aug. 31, 2018 $ 78 104,918 (23,358) 81,638
Balance (in shares) at Aug. 31, 2018 78,273      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock option exercises $ 1 41   42
Stock option exercises (in shares) 281      
Stock-based compensation   2,297   2,297
Stock-based compensation (in shares) 5      
Stock issued for acquisitions       140
Net loss       (17,494)
Balance at Feb. 28, 2019 $ 88 152,158 (40,852) 111,394
Balance (in shares) at Feb. 28, 2019 88,012      
Balance at Nov. 30, 2018 $ 79 107,256 (31,937) 75,398
Balance (in shares) at Nov. 30, 2018 78,559      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock option exercises (in shares) 89      
Stock-based compensation   3,178   3,178
Stock-based compensation (in shares) 125      
Stock sold to investors $ 9 41,584   41,593
Stock sold to investors (in shares) 9,077      
Stock issued for acquisitions   140   140
Stock issued for acquisitions (In shares) 162      
Net loss     (8,915) (8,915)
Balance at Feb. 28, 2019 $ 88 152,158 (40,852) 111,394
Balance (in shares) at Feb. 28, 2019 88,012      
Balance at Aug. 31, 2019 $ 90 164,258 (62,994) 101,354
Balance (in shares) at Aug. 31, 2019 90,041      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation $ 0 3,189 0 3,189
Stock-based compensation (in shares) 99      
Stock sold to investors $ 17 27,362   27,379
Stock sold to investors (in shares) 17,198      
Stock issued for acquisitions (In shares) 23      
Net loss     (12,506) (12,506)
Balance at Nov. 30, 2019 $ 107 194,809 (75,500) 119,416
Balance (in shares) at Nov. 30, 2019 107,361      
Balance at Aug. 31, 2019 $ 90 164,258 (62,994) 101,354
Balance (in shares) at Aug. 31, 2019 90,041      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock issued for acquisitions       0
Stock issued for equity investment       2,528
Net loss       (56,881)
Balance at Feb. 29, 2020 $ 119 215,182 (119,875) 95,426
Balance (in shares) at Feb. 29, 2020 119,118      
Balance at Nov. 30, 2019 $ 107 194,809 (75,500) 119,416
Balance (in shares) at Nov. 30, 2019 107,361      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation   3,141   3,141
Stock-based compensation (in shares) 89      
Issuance of restricted stocks (in shares) 15      
Stock sold to investors $ 10 14,706 0 14,716
Stock sold to investors (in shares) 10,000      
Stock issued for acquisitions (In shares) 0      
Stock issued for equity investment $ 2 2,526   2,528
Stock issued for equity investment (Shares) 1,653      
Net loss $ 0 0 (44,375) (44,375)
Balance at Feb. 29, 2020 $ 119 $ 215,182 $ (119,875) $ 95,426
Balance (in shares) at Feb. 29, 2020 119,118